Clinical trial
Treatment of Obsessive-Compulsive Disorder
NCT00000373 · University of Florida, Other · Completed
Key facts
| NCT number | NCT00000373 |
|---|---|
| Title | Treatment of Obsessive-Compulsive Disorder |
| Official title | Neurobiology/Treatment of Obsessive-Compulsive Disorder |
| Lead sponsor | University of Florida, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obsessive-Compulsive Disorder |
| Intervention type | Drug |
| Interventions | olanzapine + fluoxetine, placebo + fluoxetine |
| Enrollment | 74 |
| Start date | Sep 1, 1992 |
| Primary completion | Jan 1, 2003 |
| Completion | Jul 1, 2003 |
| First posted | Nov 3, 1999 |
| Last update posted | Nov 27, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: